These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 21633171

  • 1. S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy.
    Espeillac C, Mitchell C, Celton-Morizur S, Chauvin C, Koka V, Gillet C, Albrecht JH, Desdouets C, Pende M.
    J Clin Invest; 2011 Jul; 121(7):2821-32. PubMed ID: 21633171
    [Abstract] [Full Text] [Related]

  • 2. Determinants of rapamycin sensitivity in breast cancer cells.
    Noh WC, Mondesire WH, Peng J, Jian W, Zhang H, Dong J, Mills GB, Hung MC, Meric-Bernstam F.
    Clin Cancer Res; 2004 Feb 01; 10(3):1013-23. PubMed ID: 14871980
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes.
    Nelsen CJ, Rickheim DG, Tucker MM, Hansen LK, Albrecht JH.
    J Biol Chem; 2003 Feb 07; 278(6):3656-63. PubMed ID: 12446670
    [Abstract] [Full Text] [Related]

  • 6. Mechanistic Target of Rapamycin Complex 1/S6 Kinase 1 Signals Influence T Cell Activation Independently of Ribosomal Protein S6 Phosphorylation.
    Salmond RJ, Brownlie RJ, Meyuhas O, Zamoyska R.
    J Immunol; 2015 Nov 15; 195(10):4615-22. PubMed ID: 26453749
    [Abstract] [Full Text] [Related]

  • 7. The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation.
    Haga S, Ozaki M, Inoue H, Okamoto Y, Ogawa W, Takeda K, Akira S, Todo S.
    Hepatology; 2009 Jan 15; 49(1):204-14. PubMed ID: 19065678
    [Abstract] [Full Text] [Related]

  • 8. Role of S6K1 in regulation of SREBP1c expression in the liver.
    Li S, Ogawa W, Emi A, Hayashi K, Senga Y, Nomura K, Hara K, Yu D, Kasuga M.
    Biochem Biophys Res Commun; 2011 Aug 26; 412(2):197-202. PubMed ID: 21806970
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
    Julien LA, Carriere A, Moreau J, Roux PP.
    Mol Cell Biol; 2010 Feb 26; 30(4):908-21. PubMed ID: 19995915
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vitamin D Receptor Regulates Liver Regeneration After Partial Hepatectomy in Male Mice.
    Elangovan H, Stokes RA, Keane J, Chahal S, Samer C, Agoncillo M, Yu J, Chen J, Downes M, Evans RM, Liddle C, Gunton JE.
    Endocrinology; 2024 Jul 01; 165(8):. PubMed ID: 38963813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury.
    Al-Ali H, Ding Y, Slepak T, Wu W, Sun Y, Martinez Y, Xu XM, Lemmon VP, Bixby JL.
    J Neurosci; 2017 Jul 26; 37(30):7079-7095. PubMed ID: 28626016
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.
    Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J.
    Mol Cell Biol; 2004 Jan 26; 24(1):200-16. PubMed ID: 14673156
    [Abstract] [Full Text] [Related]

  • 19. Intestinal cell kinase, a MAP kinase-related kinase, regulates proliferation and G1 cell cycle progression of intestinal epithelial cells.
    Fu Z, Kim J, Vidrich A, Sturgill TW, Cohn SM.
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct 26; 297(4):G632-40. PubMed ID: 19696144
    [Abstract] [Full Text] [Related]

  • 20. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY, Hsu SC, Lee HS, Lin SH, Tsai CS, Huang SM, Shih CC, Hsu YJ.
    J Vasc Surg; 2013 Feb 26; 57(2):475-85. PubMed ID: 23265586
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.